- Research article
- Open Access
- Open Peer Review
Consultations with complementary and alternative medicine practitioners by older Australians: results from a national survey
© Yen et al.; licensee BioMed Central Ltd. 2013
- Received: 14 May 2012
- Accepted: 27 March 2013
- Published: 2 April 2013
The use of complementary and alternative medicines (CAM) and CAM practitioners is common, most frequently for the management of musculoskeletal conditions. Knowledge is limited about the use of CAM practitioners by older people, and specifically those with other long term or chronic conditions.
In 2011 we conducted an Australia wide survey targeting older adults aged over 50 years (n = 2540). Participants were asked to identify their chronic conditions, and from which health professionals they had ‘received advice or treatment from in the last 3 months’, including ‘complementary health practitioners, e.g. naturopath’. Descriptive analyses were undertaken using SPSS and STATA software.
Overall, 8.8% of respondents reported seeing a CAM practitioner in the past three months, 12.1% of women and 3.9% of men; the vast majority also consulting medical practitioners in the same period. Respondents were more likely to report consulting a CAM practitioner if they had musculoskeletal conditions (osteoporosis, arthritis), pain, or depression/anxiety. Respondents with diabetes, hypertension and asthma were least likely to report consulting a CAM practitioner. Those over 80 reported lower use of CAM practitioners than younger respondents. CAM practitioner use in a general older population was not associated with the number of chronic conditions reported, or with the socio-economic level of residence of the respondent.
Substantial numbers of older Australians with chronic conditions seek advice from CAM practitioners, particularly those with pain related conditions, but less often with conditions where there are clear treatment guidelines using conventional medicine, such as with diabetes, hypertension and asthma. Given the policy emphasis on better coordination of care for people with chronic conditions, these findings point to the importance of communication and integration of health services and suggest that the concept of the ‘treating team’ needs a broad interpretation.
- Health practitioner
- Chronic illness
Kiat and colleagues recently observed that the use of complementary & alternative medicines (CAM) can have significant interactions with standard prescription medicines for people living with cardiovascular disease (CVD) and argue the importance of mainstream healthcare practitioners being able to advise consumers about CAM use . They note estimates that as many as 42% of people with CVD take CAM . Many people use CAM to promote health and to manage health conditions, including chronic and long term conditions [2–5], but it is sometimes difficult to distinguish in the literature between the use of CAM, which can be obtained from a variety of sources, including high street pharmacies and supermarkets, from the use of services provided by a range of complementary or alternative health practitioners (CAM practitioner). In addition to the possible interactive effects in combining CAM with prescribed medicines, seeking the advice or treatment of a CAM practitioner such as a naturopath or acupuncturist raises implications for people with chronic conditions in ensuring that care management is both coordinated and effective across the range of practitioners consulted. Limited information is available about the use of CAM practitioners by older people, amongst whom chronic illness is most common.
Based on survey interviews with 3004 people in 1993, MacLennan and colleagues reported in 1996 that one in five people in Australia (20.3%) had ever attended a non-medically trained CAM practitioner . Eighteen years after the study was undertaken the works of MacLennan and colleagues remain highly cited as the authorities on prevalence of CAM and CAM practitioner use in Australia [7–9]. More recently, in 2003 Adams and colleagues reported findings from the Australian Longitudinal Study on Women’s Health, showing that women in the middle aged group of 45–50 years of age were more likely than younger (18–23 years) or older women (70–75 years) to have consulted a CAM practitioner in the last 12 months. In addition, in all age groups, users of CAM were more likely to reside in non-urban areas, have more symptoms and illness, and be higher users of mainstream healthcare practitioners [10, 11]. They found that 28% of women in the middle aged group and 15% of women in the older age group reported consulting CAM practitioners . Xue and colleagues  note the CAM industry is growing and is now a multi-billion dollar industry. They report that 44.1% of adults in their Australian-wide study reported visiting a CAM practitioner in the past twelve month period, with females more likely than males to use CAM . Robinson & McGrail’s 2004 literature review found several studies that suggest CAM use may be even higher .
The majority of studies of CAM use have been carried out in the US, including, for example, work by Goldstein, who has reported, inter alia, on the use of CAM among California adults with, and without cancer , and with Hsiao et al.  has explored the significance of ethnic background in the use of CAM. In a narrative review relating to CAM use in the general population, Bishop and Lewis  conclude that knowledge in the area would be well served by further research exploring specific issues, and suggest looking at predictors of particular CAM use, and the association between CAM use and individual demographic or health characteristics.
Adams et al. (2010) examined the use of CAM and CAM practitioners using participants in a cohort study and found that those using CAM practitioners tended to be younger, female, with higher education levels and above average incomes . This study also reported use of CAM practitioners by condition: respondents with non-arthritic joint pain; and those with mild to moderate depressive symptoms were the more likely to consult a CAM practitioner. In Kristofferson’s Norwegian study of CAM practitioner use, 9.5% of people with no previous diagnosis of cancer or coronary heart disease reported having seen a CAM practitioner in the past 12 months. Almost 8% of people with a previous diagnosis of cancer and 6.4% of people with coronary heart disease reported the same . These numbers are slightly higher than Greenfield and colleagues’ British study of CAM use (including CAM practitioners), where 8.1% of survey respondents reported using CAM to self-manage coronary heart disease .
Thomas  in the UK found that 71% of CAM practitioner consultations related to musculoskeletal conditions. We were able to identify only one study reporting the use of CAM practitioners according to chronic condition within a general population that specifically included older people . In that study, Al-Windi  reported that being middle-aged (25–64 years) and having a diagnosed chronic condition were significantly associated with higher use of CAM practitioners. In a study of provider based CAM use, Sirois found that those factors predicting CAM provider use in the general population; being female, having a higher education level and a higher number of comorbid conditions; held across three illness groups they included, arthritis, inflammatory bowel disease and mixed chronic conditions.
In this paper, we ask what factors are associated with use of CAM practitioners by older Australians living in the community, and discuss those findings in the context of chronic illness management.
In February 2011 the Serious and Continuing Illness Policy and Practice Study (SCIPPS) conducted an Australia wide mail survey targeting people aged over 50 years, about time use and co-ordination in relation to chronic illness. The survey design, the sampling method, the survey process and analytic method are outlined below.
The survey was designed to cover three main areas. The first elicited information on standard demographic variables. The second related to the respondent’s health, and asked respondents for their perceptions of their own health using the standard single question measure of self-assessed health. In addition, respondents were asked to nominate chronic diseases with which they had been formally diagnosed, including those from a list of common chronic conditions. Respondents were asked about their health services use, including type and number of health professionals consulted in the previous three months. The final section contained a series of questions to obtain information about co-ordination of care and time spent on health related activity.
The questionnaire was piloted with 18 members of a local health service consumer network, who suggested changes to terminology, simplification of questions and shortening the survey. The amended survey was completed by a further 28 people who were respondents to a previous survey of older Australians by the same team and had indicated their willingness to be involved in further research studies. No further changes were suggested.
People aged over 50 years with one or more of Type 2 Diabetes, Chronic Obstructive Pulmonary Disease and Cardiovascular disease were the subject group of a wider study of which this work is part, the Serious and Continuing Illness Policy and Practice Study. To ensure that we were able to obtain a good understanding of chronic illness experience, this participant sample was drawn from members aged over 50 years of three organisations: one which broadly represents all older Australians and two which relate to particular disease conditions.
The three sample pools were: National Seniors Australia, (a non- profit organisation representing Australians aged 50 and over with 285,000 members), the National Diabetes Services Scheme (NDSS) (a government funded service delivering subsidised diabetes supplies, information and support for people with diabetes with 280,000 registrants aged over 50) and the Australian Lung Foundation (a non-profit, advocacy, education, fund raising and support organization with over 14,000 members). We refer to respondents as being part of either the ‘NSA sample’, the ‘Diabetes sample’ or the ‘Lung sample’.
A sample of 5,000 members was drawn from the NSA members, stratified by State of residence and age with an oversampling of older members to increase the proportions with chronic disease. A sample of 2,500 registrants aged 50 years or over was drawn from the NDSS register, stratified by State, age and gender with no oversampling as the scheme operates specifically to subsidise costs for persons with diabetes. A sample of 3,062 members of the Australian Lung Foundation was also drawn, comprising all their members with chronic obstructive pulmonary disease (COPD).
The survey was mailed out to the selected sample, with information about the survey in a letter accompanying the survey form. This letter informed recipients about the reason for the survey and what it hoped to achieve, that the survey was voluntary, and provided contact information to enable the recipient to contact the research leader or the relevant Ethics committee with any concerns. Recipients were offered a choice of responding on line, using Survey Monkey®, a proprietary survey tool, or by completing the survey form and returning it by prepaid post. Recipients were informed that return of the survey was taken to signify consent to take part.
Study approval was obtained from the Australian National University Human Research Ethics Committee (Protocol number: 2010/468).
Data collection and analysis
Data were scanned and entered into SPSS files for analysis. On line responses were merged electronically. Analysis was undertaken using SPSS Version 19 (Somers, NY, USA) and Stata 9 (College Station, TX, USA).
The complex stratified sample structure and the variable response rates meant that separate weighting was needed for each sub-sample to allow estimates of each of the three populations, and all estimates provided here are weighted. The responding NSA sample (n = 1432) is broadly representative of older Australians, although they are somewhat more affluent and better educated than the aged population as a whole. The majority of this paper is based on the NSA sample because it is representative of older Australians , although the other samples are referenced where this information adds to understanding of how chronic conditions influence access.
The number of responses completed and included was 2,540. The NSA sample included 1,432 respondents (28.6% response rate). The Lung sample included 681 respondents (22.2% response rate) and the Diabetes sample included 427 respondents (17.1% response rate).
Proportions of people in the NSA sample (1,432 respondents) with chronic conditions who attend complementary medicine practitioners
Number of respondents
Percent of people with condition attending a complementary practitioner
95% confidence interval
High blood pressure
Use of CAM practitioners
Respondents were asked to identify which health professionals they had ‘received advice or treatment from in the last 3 months’, including ‘complementary health practitioners, e.g. naturopath’. Overall, 8.8% of NSA respondents reported seeing a CAM practitioner in the past three months, (12.1% of women and 3.9% of men). In comparison, 3.9% of the Diabetes sample, and 3.4% of the Lung sample, reported consulting a CAM practitioner during that period. In the NSA group, 5.6% reported between one and three visits to a CAM practitioner in the previous 3 months with 1.2% reporting 4–5 visits and 1% reporting more than 6 in the same period. Most people who consulted a CAM practitioner had also consulted a general practitioner or medical specialist within the same period, (95% of the Diabetes respondents, 100% of the Lung respondents, and 85% of NSA respondents.) Within the NSA group, 15% reported that they had seen a CAM practitioner, but not a medical practitioner, within the previous 3 months.
Table 1 presents the percentage of NSA respondents with one or more of ten chronic conditions that were included in the survey, together with the percentage of respondents with each illness who reported consulting a CAM practitioner in the past three months.
Broadly speaking the table suggests that those with pain-associated or mobility limiting conditions were more likely to consult CAM practitioners than those with other conditions. Respondents with musculoskeletal conditions such as osteoporosis, or chronic pain, were significantly more likely to have seen have seen a CAM practitioner in the previous three months than respondents with cancer (ever treated), high blood pressure, diabetes or asthma. With the relatively wide confidence intervals due to small numbers with each condition no other differences are significant, although the estimated proportions of people with depression or anxiety or with renal conditions CAM practitioner are relatively high at 12%.
Use of CAM practitioner by number of chronic conditions and sample type
Number of respondents
Percent of people in this sample and with this number of conditions attending a complementary practitioner
95% confidence interval
Number of chronic conditions
5 or more
Number of chronic conditions
5 or more
Lung Foundation Sample
Number of chronic conditions
5 or more
Although confidence intervals are very wide, there is a pattern in the Diabetes sample of increasing numbers of chronic conditions being associated with higher percentages using CAM practitioners, with a similar pattern in the Lung sample up to 4 conditions, although with smaller use of CAM practitioners in the group with most chronic conditions. However, this trend is not evident in the NSA sample, where there is no pattern that is significantly associated with number of conditions.
Demographic patterns of users of CAM practitioners in the NSA sample
Number of respondents
Percent of NSA members in this category attending a complementary medical practitioner
95% confidence interval
All NSA members
80 years or over
Other employment status
No post-school qualifications
Post school qualifications but no degree
Degree or higher degree
Socio-economic status (SES) of area of residence
First quintile (lowest SES)
Fifth quintile (highest SES)
Note some groups do not add to 1,432 due to missing values
Inner Regional Areas
Outer Regional Areas
Number of chronic conditions
5 or more
Women were significantly more likely than men to use CAM practitioners, and the elderly (over 80 years of age) significantly less likely than those aged 50–69 years. Those with degree qualifications were more likely than those with no post school qualifications to use CAM practitioners. Respondents living in remote areas were significantly less likely than those in inner regional or metropolitan areas to report using CAM practitioners. No significant differences in use were found in relation to employment status or socio-economic status of the area of residence. There was no significant difference in CAM practitioner use in relation to self-assessed health or (as noted above) the number of chronic conditions reported.
This study is the only national study specifically to report use of CAM practitioners by older Australians who have chronic illness. Overall, 8.8% of our NSA sample, most closely representative of the wider population of older Australians, reported seeing a CAM practitioner in the previous three months. In common with other studies, we found that those who consult CAM practitioners are likely to be women and to have higher levels of education. However, in contrast with other studies [12, 17], we did not find that living in an area of higher socioeconomic status was related to higher use. We have also been able to show a differentiation in use with a decline in use with increasing age, with those over 80 years of age being the lowest users. In contrast to the Adams study  where 3.1% of those over 65 years visited CAM practitioners over the past year, our NSA sample showed use by 10.1% of those aged between 60 and 69 years; and 7.2% of those aged between 70 and 79 years in the past 3 months. It was only in the group of those aged 80 and above that the rate of use fell to 2.6%.
The different methodologies used by researchers in this area make direct comparisons of rates of use difficult. Many of the studies cited report CAM practitioner use over the previous twelve months (8, 17,) rather than the 3 months used in this study and use different age groupings and include different CAM practitioners. However, the proportions of those consulting CAM practitioners in the previous 3 months, at 8.8%, is at least as great as those reported by Adams  and more in line with the 26.5% rate reported by MacLennan and colleagues .
The gender difference in use is wider in our study (almost 3 F:1 M) than in other studies that report a 2:1 difference  but the reasons for this are not clear.
Studies looking at specific chronic conditions have found similar CAM usage to that in our study. In our study, 8.4% of respondents with recent treatment for cancer and 8.8% of respondents with a heart condition in the NSA sample reported accessing CAM practitioners. We found higher use of CAM practitioners among people with musculoskeletal conditions such as arthritis (9.2%), osteoporosis (15.9%) and chronic pain (13.0%) than cancer and heart disease. These figures are higher than those reported by Adams et al.  (5.6%, 4.4% and 8.5% respectively), even when reporting a shorter period.
While Westert et al.  have shown that use of health services increases with increasing ill-health and numbers of co-morbid conditions, the current study found that this did not apply to the use of CAM practitioners: neither self-assessed health nor the reported increasing numbers of chronic conditions was significantly related to their reported use. This may suggest that the reasons for consulting a CAM practitioner are linked to the presence of particular conditions, so that the actual number of conditions is less important, or, as other authors have suggested that it is related to the patient ‘world view’ in making their choice of provider  especially when “conventional care is not relieving their symptoms” .
This possibility is supported by the fact that the two chronic condition samples (Diabetes and Lung), for which conventional medicine has clear guidelines and treatment models had low CAM use.
Finally, respondents living in remote areas were significantly less likely than those in inner regional or metropolitan areas to report using CAM practitioners, a finding that may be related to the limited number of CAM (and other) practitioners in Australia’s remote areas, but that contrasts with Adams’ 2003 findings .
There is no commonly used group of practitioners included under a definition of CAM practitioner, and our study left it open to respondents to include CAM practitioners according to their own views. There is no capacity in this study as a result to link particular respondent characteristics to particular practitioners. Additionally the survey did not capture whether respondents saw mainstream healthcare practitioners who have been trained in CAM .
Using recall as the basis for data may lead to inaccurate reporting, which we hoped to minimise by using a limited period, particularly in relation to the number of times respondents consulted different health practitioners.
Our survey did not ask respondents whether they sought care from a particular practitioner in connection with a particular chronic disease or other health issue . It is possible that people with diabetes, for example, were accessing CAM practitioners for management of other conditions or to improve overall health .
The response rate from each of the sample groups is lower than we had hoped, which limited the analysis of all variables, and inevitably leads to a concern that these results are not representative. On the other hand, responses were received from respondents nationally, which provides a strength to the results.
Implications for management of chronic illness
The vast majority of those who consulted CAM practitioners also consulted mainstream medical professionals, almost universally in the case of respondents from both the Diabetes group and the Lung group. Respondents with conditions that have well evidenced treatment regimes that are widely used, such as hypertension, diabetes and asthma, have the smallest percentage seeking advice or treatment from CAM practitioners. On the other hand, higher proportions of people with conditions that are complex, involve pain management, and whose effects may be intractable using conventional medicines report seeking assistance from CAM practitioners.
We suggest that these findings have particular implications for mainstream healthcare practitioners. Other studies have shown that the combination of multiple care practitioners, as well as multiple medicines affect the wellbeing of people with chronic conditions [27, 28]. For this reason it is important that mainstream healthcare practitioners be aware of the healthcare choices their clients are making.
Robinson & McGrail’s literature review of disclosure of CAM and CAM practitioner usage found that the disclosure rate of usage to mainstream healthcare practitioners may be as low as 23%, with several reviewed studies reporting non-disclosure rates of 60-70% . The reasons for this include, but are not limited to, patient perception that the physician does not value CAM, physician is viewed as ignorant of CAM, physician does not ask about CAM usage, patient forgets to mention CAM usage . The disclosure of CAM usage to mainstream healthcare practitioners is essential, as Kiat and colleagues have suggested, to patient outcomes .
Our data suggests in addition that since a substantial percentage of consumers with chronic conditions seek advice from CAM practitioners, it is important to consider the active role of CAM practitioners as part of overall health care planning and management. Like mainstream healthcare practitioners, CAM practitioners are likely to be in a position of trust and confidence with the consumer. The potential exists for adverse effects to result not only from competing medicines, but from competing advice. Sewitch et al. suggest that increased knowledge of CAM efficacy and increased mainstream healthcare practitioners’ knowledge of CAM therapies will “help integrate CAM into mainstream medical care”  at 151]. In previous SCIPPS work [30, 31] we note that competing medication regimes and competing advice about care are reported as significant barriers to best care by both consumers and care practitioners. Commenting on service fragmentations, a nursing manager said:
[Consumers] often express their concern that professionals aren’t talking to each other, aren’t linking up. It’s very disheartening for them to go and see a GP in their community setting, try to see a podiatrist maybe privately, and a nutritionist somewhere else. And the question they often ask me is ‘why don’t these people ever speak to each other to co-ordinate my care?’ (31: 7).
This quote speaks of fragmentation between medical health and allied health care professionals, but such fragmentation may be even more evident with CAM practitioners, especially given the reluctance of many to declare use of CAM to their general practitioner. Improving communication and integration of health services is essential to providing comprehensive care and we suggest that the concept of the ‘treating team’ needs a broad interpretation.
We recommend that questions about the use of CAM and consultations with CAM practitioners should be raised by health care practitioners in bio-medical consultations as a matter of standard procedure. Particularly in the case of clients with osteoporosis and other conditions where pain and pain management are a feature, regular discussions about CAM therapy and practitioner use is important to foster patient safety and best multidisciplinary practice.
The Serious and Continuing Illness Policy and Practice Study (SCIPPS) is an NHMRC-funded program (no: 402793) conducted at The Australian National University and the University of Sydney and administered by the Menzies Centre for Health Policy.
We thank the other members of the team for their collegial support; National Seniors Australia, The National Diabetes Subsidy Scheme and the Lung Foundation for their assistance in recruiting the respondents; and in particular, the respondents whose generosity in completing the survey allowed the work to be done.
- Kiat H, Sun Bin Y, Grant S, Hsu-Tung CD: Complementary medicine use in cardiovascular disease: a clinician’s viewpoint. Medical J Australia. 2011, 195 (11/12): 654-656.View ArticleGoogle Scholar
- Barraco D, Valencia G, Riba AL, Nareddy S, Draus CBSN, Schwartz SM: Complementary and alternative medicine (CAM) use patterns and disclosure to physicians in acute coronary syndromes patients. Complement Ther Med. 2005, 13 (1): 34-40. 10.1016/j.ctim.2005.02.003.View ArticlePubMedGoogle Scholar
- Yeh GY, Davis RB, Phillips RS: Use of Complementary Therapies in Patients With Cardiovascular Disease. Am J Cardiol. 2006, 98 (5): 673-680. 10.1016/j.amjcard.2006.03.051.View ArticlePubMedGoogle Scholar
- Unantenne N, Warren N, Canaway R, Manderson L: The Strength to Cope: Spirituality and Faith in Chronic Disease. J Relig Health. 2011, 1-15.Google Scholar
- Ernst E: Prevalence of use of complementary/alternative medicine: a systematic review. Bull World Health Organ. 2000, 78: 258-266.Google Scholar
- MacLennan A, Wilson D, Taylor A: Prevalence and cost of alternative medicine in Australia. Lancet. 1996, 347: 569-573. 10.1016/S0140-6736(96)91271-4.View ArticlePubMedGoogle Scholar
- MacLennan A, Wilson D, Taylor A: The escalating cost and prevalence of alternative medicine. Prev Med. 2002, 35: 116-173.View ArticleGoogle Scholar
- MacLennan A, Myers S, Taylor A: The continuing use of complementary and alternative medicine in South Australia: costs and beliefs in 2004. Med J Australia. 2006, 184 (1): 27-31.PubMedGoogle Scholar
- Sanderson CR, Koczwara B, Currow DC: The “therapeutic footprint” of medical, complementary and alternative therapies and a doctor’s duty of care. Med J Australia. [Perspective]. 2006, 185 (7): 373-376.Google Scholar
- Adams J, Sibritt DW, Easthope G, Young AF: The profile of women who consult Complementary Health Practitioners in Australia. Med J Australia. 2003, 179: 297-300.PubMedGoogle Scholar
- McLaughlin D, Lui C-W, Adams J: Complementary and alternative medicine use among older Australian women - a qualitative analysis. BMC Complement Altern Med. 2012, 12 (1): 34-10.1186/1472-6882-12-34.View ArticlePubMedPubMed CentralGoogle Scholar
- Xue CCL, Zhang AL, Lin V, Da Costa C, Story DF: Complementary and Alternative Medicine Use in Australia: A National Population-Based Survey. J Altern Complement Med. 2007, 13 (6): 643-650. 10.1089/acm.2006.6355.View ArticlePubMedGoogle Scholar
- Robinson A, McGrail MR: Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med. 2004, 12 (2–3): 90-98.View ArticlePubMedGoogle Scholar
- Goldstein MS, Brown ER, Ballard-Barbash R, Morgenstern H, Bastani R, Lee J: The Use of Complementary and Alternative Medicine Among California Adults With and Without Cancer. eComplementary and Alternative Medicine. [Original]. 2005, 2 (4): 557-565.View ArticleGoogle Scholar
- Hsiao A-F, Wong MD, Goldstein MS, Becerra LS, Cheng EM, Wenger NS: Complementary and elaternative medicine use among Asian-American subgroups: prevalence, predictors, and lack of relationship to accultruation and access to conventional care. J Altern Complementary Med. [Original artcle]. 2007, 12: 1003-1010.View ArticleGoogle Scholar
- Bishop FL, Yardley L, Lewith GT: A Systematic Review of Beliefs Involved in the Use of Complementary and Alternative Medicine. J Health Psychol. 2007, 12 (6): 851-867. 10.1177/1359105307082447.View ArticlePubMedGoogle Scholar
- Adams RJ, Appleton SL, Cole A, Gill T, Taylor AW, Hill CL: Oral complementary medicine and alternative practitioner use varies across chronic conditions and attitudes to risk. Clin Epidemiol. 2010, 2 (1): 251-260.View ArticlePubMedPubMed CentralGoogle Scholar
- Kristoffersen AE, Norheim AJ, Fønnebø VM: Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD. BMC Complement Altern Med. 2012, 12 (1): 1-8. 10.1186/1472-6882-12-1.View ArticlePubMedPubMed CentralGoogle Scholar
- Greenfield S, Pattison H, Jolly K: Use of complementary and alternative medicine and self-tests by coronary heart disease patients. BMC Complement Altern Med. 2008, 8 (47): 1-8.Google Scholar
- Thomas KJ, Nicholl JP, Coleman P: Use and expenditure on complementary medicine in England: a population based survey. Complement Ther Med. 2001, 9: 2-11. 10.1054/ctim.2000.0407.View ArticlePubMedGoogle Scholar
- Al-Windi A: Determinants of complementary alternative medicine (CAM) use. Complement Ther Med. 2004, 12 (2–3): 99-111.View ArticlePubMedGoogle Scholar
- Sirois F: Provider-based complementary and alternative medicine use among three chronic illness groups: associations with psychosocial factors and concurrent use of conventional health-care services. Complement Ther Med. 2008, 16 (2): 74-81.View ArticleGoogle Scholar
- Yen L, McRae I, Jeon YH, Essue B, Herath P: The impact of chronic illness on workforce participation and the need for assistance with household tasks and personal care by older Australians. Health Soc Care Community. 2011, 19 (5): 485-494. 10.1111/j.1365-2524.2011.00994.x.View ArticlePubMedGoogle Scholar
- Westert GP, Satariano W, Schellevis FG, Van Den Bos GAM: Patterns of comorbidity and the use of health services in the Dutch population. Eur J Public Health. 2001, 11 (4): 365-372. 10.1093/eurpub/11.4.365.View ArticlePubMedGoogle Scholar
- Testerman JK, Morton KR, Mason RA, Ronan AM: Patient motivations for using complementary and alternative medicine. Complementary Health Prac Rev. 2004, 9: 81-92.Google Scholar
- Pirotta MV, Cohen MM, Kotsirilos V, Farish SJ: Complementary therapies: have they become accepted in general practice?. Med J Australia. 2000, 172: 105-109.PubMedGoogle Scholar
- Braun LA, Tiralongo E, Wilkinson JM, Poole S, Spitzer O, Bailey M: Adverse reactions to complementary medicines: the Australian pharmacy experience. Int J Pharm Pract. 2010, 18 (4): 242-244. 10.1111/j.2042-7174.2010.00036.x.View ArticlePubMedGoogle Scholar
- Elmer GW, Lafferty WE, Tyree PT, Lind BK: Potential Interactions Between Complementary/Alternative Products and Conventional Medicines in a Medicare Population. Ann Pharmacother. 2007, 41: 1617-1624. 10.1345/aph.1K221.View ArticlePubMedPubMed CentralGoogle Scholar
- Sewitch MJ, Cepoiu M, Rigillo N, Sproule D: A Literature Review of Health Care Professional Attitudes Toward Complementary and Alternative Medicine. Complement Heal Pract Rev. 2008, 13 (3): 139-154.Google Scholar
- Jeon Y-H, Jowsey T, Yen L, Glasgow NJ, Essue B, Kljakovic M: Achieving a balanced life in the face of chronic illness. Australian J Primary Health. 2010, 16: 66-74. 10.1071/PY09039.View ArticleGoogle Scholar
- Yen L, Gillespie J, Jeon Y-H, Kljakovic M, Brien J-a, Jan S: Health professionals, patients and chronic illness policy: a qualitative study. Heal Expect. 2011, 14 (1): 10-20. 10.1111/j.1369-7625.2010.00604.x.View ArticleGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/13/73/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.